CAIRE Research Sponsor Advisory Board

CAIRE’s Research Sponsor Advisory Board (RSA) brings together executive committee members, key stakeholders and industry sponsors twice a year to facilitate dialogue on relevant topics.

Overview

CAIRE’s Research Sponsor Advisory Board (RSA) brings together executive committee members, key stakeholders and industry sponsors twice a year to facilitate dialogue on topics such as applied vaccinology research in Canada, methods for timely access to new and improved vaccines, collaborations to ensure suitable expertise and facilities exist in Canada, and vaccine research practices in Canada.

Recent topics discussed include:

·        Immunization policy decision making in Canada

·        COVID-19 vaccines and priority populations: Children and pregnant individuals

·        Research during outbreaks

·        Managing real and perceived conflict of interest

Related Resources

Featured
Summary of Discussion: The Canadian vaccinology landscape in a global context

This meeting presented opportunities for discussion on which factors make Canada an attractive place to undertake vaccine research, and what are the barriers that make Canada less competitive. Through having perspectives from different stakeholders, this meeting was able to explore how the Canadian landscape fares with other key countries/regions as well as to strategize potential solutions to minimize barriers.

Summary of Discussion: Recommended but non-funded vaccines: Perspectives from different stakeholders

The overall goal of this meeting is to present current issues with regards to approved and recommended vaccines that are not included in publicly funded programs from different viewpoints. In addition, the meeting will discuss potential solutions to address these challenges.

Summary of Discussion: Developing and implementing vaccine recommendations in Canada during the COVID-19 pandemic

The overall goal of this meeting was to discuss how vaccination recommendations were developed and implemented across Canada during the COVID-19 pandemic, including how provinces and territories (PT) balanced the guidance provided by the National Advisory Committee on Immunization (NACI) with local considerations while implementing their COVID-19 vaccination programs.